Acella Pharmaceuticals, LLC has recently issued a voluntary recall of 38 lots of NP Thyroid, Thyroid Tablets, USP after routine testing found these lots to be subpotent. The recalled lots of 15-mg, 30-mg, 60-mg, 90-mg and 120-mg tabs contain less than 90% of the labeled amount of liothyronine and/or levothyroxine.
Patients who have received the these sub potent drugs may experience signs and symptoms of hypothyroidism (underactive thyroid) including fatigue, increased sensitivity to cold, constipation, dry skin, puffy face, hair loss, slow heart rate, depression, swelling of the thyroid gland, and unexplained weight gain or difficulty losing weight.
There is a reasonable risk of injury to newborn infants or pregnant women with hypothyroidism including early miscarriage, fetal hypothyroidism, and/or impairments to fetal neural and skeletal development. In elderly patients with underlying cardiac disease, toxic cardiac manifestations of hyperthyroidism (overactive thyroid) may occur, such as cardiac pain, palpitations or arrhythmia.
To date, Acella has received 43 reports of serious adverse events that are potentially related to the recall. If you are a patient taking any of the affected lots of NP Thyroid and have experienced severe side effects, don’t wait to contact the team of experienced attorneys at Cellino Law. Call our team of experienced attorneys at 800-555-5555 for your free case consultation.